White Paper: Technology and the Value of Independent Medical Education to Stakeholders

A white paper by IQVIA breaks down the importance of technology for grants professionals involved in funding independent medical education (IME). Pharma companies sponsoring IME programs must navigate ethical concerns and find ways to accurately assess and communicate the value of grant proposals to stakeholders. Grants professionals fill this role and must rely on technology and data-driven insights to make funding decisions.

According to the white paper, “Determining and measuring the success of grants is often complex. The more meaningful the desired outcome, the more challenging it is to measure the actual results. For example, measuring the actual change in community or patient health outcomes that are associated with an educational intervention requires longitudinal analysis of claims data, chart data, or similar data sources. Measuring change in participants’ knowledge, on the other hand, may be accomplished with pre- and post-testing.”

Download the white paper by clicking here.

(Source: Medical Affairs, January 7^th, 2022)